Compare Meta Platforms Inc (META) vs Oruka Therapeutics Inc. Common Stock (ORKA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Meta Platforms Inc vs Oruka Therapeutics Inc. Common Stock — how do they compare? Meta Platforms Inc trades at $727.11 (market cap $1.94T), while Oruka Therapeutics Inc. Common Stock trades at $75.2 (market cap $5.18B). The key difference: Meta Platforms Inc is far larger — about 374.5× Oruka Therapeutics Inc. Common Stock's market cap, and Meta Platforms Inc pays a 0.28% dividend while Oruka Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Meta Platforms Inc for 128 Days and Oruka Therapeutics Inc. Common Stock for 0 Days on average.
| META | ORKA | |
|---|---|---|
Market Cap | $1.94T | $5.18B |
Volume | 22,627,792 | 490,798 |
Sector | Media | Health |
52-Week High | $777.59 | $113.08 |
52-Week Low | $525.72 | $26.19 |
Typical Hold Time | 128 Days | 0 Days |
Enterprise Value | $1.96T | $4.31B |
Dividend Yield | 0.28% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Meta Platforms (META) trades at $737.54, down 0.73% on the day, with strong bullish technical signals from moving averages and ADX indicators. The company demonstrates robust fundamentals with $201B revenue in 2025, 29.8% net margin, and consistent earnings beats in recent quarters. Recent AI developments including Muse Spark launch and a $21B CoreWeave deal highlight growth initiatives.
Wall Street maintains strong bullish sentiment with 80% buy ratings and $802.80 consensus target, representing 9% upside. Key risks include ongoing youth addiction litigation in Massachusetts and elevated capital expenditures for AI infrastructure. The stock presents growth potential through AI monetization but faces regulatory and execution challenges.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Meta Platforms Inc
Meta Platforms Inc., doing business as Meta and previously known as Facebook Inc. It's a company that acts as a parent platform for Facebook, Messenger, Instagram, Whatsapp, Oculus and other subsidiaries. Among these platforms, Facebook is the number one social media platform in terms of the number of active users.
Read more on META →About Oruka Therapeutics Inc. Common Stock
Oruka Therapeutics, Inc. is a clinical-stage biotechnology company developing extended half-life monoclonal antibodies for plaque psoriasis, psoriatic arthritis, and related dermatologic conditions, with lead candidates ORKA-001 and ORKA-002 in clinical trials.
Read more on ORKA →
